Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 502 of 5804
-
Anti-Aging drug and football drills join forces to fight brittle bones
Prevention OngoingIt is estimated that women lose around 20-25% of bone mass during the 5-10 years period of postmenopausal transition, and menopause is considered a major risk factor for osteoporotic fragility fracture. Currently, there is no preventive strategy to counteract these changes, and h…
Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Immunotherapy combo shows promise in hodgkin lymphoma trial
Disease control Recruiting nowPatients in this prospective multicenter phase II study will be randomized between two first-line therapy strategies for advanced stages of cHL. In the Nivo-AVD cohort, patients will receive 2 cycles of nivolumab monotherapy followed by a switch to Nivo-AVD combination therapy (t…
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a healthy Person's nose bacteria cure sinusitis?
Disease control Recruiting nowChronic rhinosinusitis (CRS) is a disease associated with impaired quality of life and substantial societal costs. Much is still uncertain regarding the underlying etiology of the disease. Current treatment protocols are based on observed effects rather than a mechanistic underst…
Phase: PHASE2, PHASE3 • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Immune cells from your own tumor could fight lung cancer
Disease control Recruiting now20 participants are expected to be enrolled for the Phase Ib clinical trial,this trail is expected to be finished in 36 months.
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Spinal implant and robot suit help paralyzed patients take steps
Disease control CompletedSpinal cord injury (SCI) can be caused by trauma, inflammation, tumors, and other factors, often leading to issues such as impaired leg movement, abnormal sensation, and difficulties with bladder and bowel control. These challenges significantly affect the patient's quality of li…
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Stroke recovery: which blood pressure target works best?
Disease control Recruiting nowSeveral clinical trials have produced variable conclusions regarding the effects of intensive blood pressure (BP) lowering in post-EVT acute ischaemic stroke (AIS) patients. Although two trials indicate harm from very intensive target-based treatment (SBP \<130 mmHg), the others …
Phase: NA • Sponsor: The George Institute • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug duo aims to tame Graft-Versus-Host disease
Disease control OngoingThis study will be conducted to determine the preliminary efficacy of axatilimab in combination with ruxolitinib and to assess the contribution of axatilimab to the combination treatment effect in participants with cGVHD.
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a single dose of radiation before surgery replace weeks of treatment?
Disease control Recruiting now1\. Efficacy of PULSAR preoperative radiation 2. Evaluate potential of microbubble CEUS as an alternative to operative SLNBx 3. Evaluate potential of OA to evaluate treatment response of pre-operative radiation on the tumor
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could 3 chemo rounds be enough? new trial aims to cut treatment burden
Disease control Recruiting nowMulticenter, randomized, open label study including patients with advanced HRDpositive high-grade ovarian cancer, fallopian tube cancer, primary peritoneal cancer and clear cell carcinoma of the ovary with no residual tumor mass following primary tumor debulking to determine recu…
Phase: PHASE2 • Sponsor: North Eastern German Society of Gynaecological Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo aims to tame rare childhood leukemia
Disease control Recruiting nowThis clinical trial will test the safety and efficacy of combining trametinib and azacitidine in patients with juvenile myelomonocytic leukemia (JMML). Newly diagnosed lower-risk JMML patients will receive trametinib and azacitidine. High-risk JMML patients will receive trametini…
Phase: PHASE1, PHASE2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New pill targets HER2 cancers in phase 2 trial
Disease control Recruiting nowThis is a study for people with advanced cancer for whom previous treatment was not successful. Adults aged 18 and over with advanced cancer with HER2 alterations can join the study. The purpose of this study is to find out whether a medicine called zongertinib helps people with …
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Heart attack prevention showdown: smart imaging vs. pills alone
Disease control Recruiting nowThe overall purpose of ACCURATE II trial is to compare the clinical outcomes of CT-derived FFR guided strategy versus medical therapy in patients with chronic coronary syndrome.
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Zap away heart flutters: new device trial offers hope for AF patients
Disease control Ongoing\### Study Overview * Study Name In simple terms, this study involves using a new device to treat a heart condition called "Paroxysmal Atrial Fibrillation." * Sponsor The study is sponsored by a company called Shanghai Shangyang Medical Technology Co., Ltd. * Trial Devices The …
Phase: NA • Sponsor: Shanghai Shangyang Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug acolbifene takes on tamoxifen in breast cancer prevention trial
Prevention Recruiting nowThis phase IIA trial compares the effect of acolbifene versus low dose tamoxifen in preventing breast cancer in premenopausal women at high risk for developing breast cancer. The usual approach for patients at increased risk for breast cancer is to undergo yearly breast magnetic …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
New drug could soothe uncontrollable itch in rare skin condition
Symptom relief OngoingThe purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New hope for tough brain tumors: drug combo trial launches
Disease control Recruiting nowThis study is a prospective, single-arm clinical trial aimed at evaluating the safety and efficacy of ivoximab combined with temozolomide in the treatment of relapsed/refractory glioma. The study plans to enroll 29 patients with relapsed/refractory glioma. After signing informed …
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a simple swab catch uterine cancer before it spreads?
Diagnosis Recruiting nowThe study goal is to investigate a non-invasive approach to predict endometrial cancer (EC) risk, better understand disease progression and identify opportunities for intervention. This two-part case-cohort prospective study will recruit patients whose abnormal uterine bleeding …
Sponsor: University of British Columbia • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Gene therapy targets second eye in rare blindness disorder
Disease control OngoingThe purpose of this study is to assess the safety and tolerability of subretinal delivery of Adeno-associated Virus Vector (AAV5 hRKp.RPGR) gene therapy in adults and children with X-linked retinitis pigmentosa.
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Exercise prescription: a new weapon against stroke?
Prevention OngoingThe objective of this study is to evaluate the effectiveness and safety of regular physical exercise in preventing ischemic stroke events in patients with symptomatic intracranial arterial stenosis.
Phase: PHASE3 • Sponsor: Capital Medical University • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
New shot aims to stop migraines before they start
Prevention Recruiting nowA migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Migraines are caused by a series of events when the brain gets stimulated …
Phase: PHASE2 • Sponsor: Ipsen • Aim: Prevention
Last updated Jul 10, 2026 00:00 UTC